Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarita Dubey

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Oncologist|April 12, 2005
Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximabSarita Dubey, Joan H Schiller
Hematology/Oncology Clinics of North America|March 10, 2004
Chemotherapy for advanced non-small cell lung cancerSarita Dubey, Joan H Schiller
The Oncologist|April 5, 2007
Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I diseaseHeather Wakelee, Sarita Dubey, David Gandara
The Lancet. Oncology|May 2, 2006
Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyondSarita Dubey, Jill M Siegfried, Anne M Traynor
Oncology|August 12, 2010
Smoking cessation: an integral part of lung cancer treatmentJanine K Cataldo, Sarita Dubey, Jodi J Prochaska
The Journal of Supportive Oncology|March 31, 2005
Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancerSarita Dubey, Roger L Brown, Sarah L Esmond, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 6, 2006
Phase I study of docetaxel and topotecan in patients with advanced malignanciesSarita Dubey, Paul Hutson, Dona Alberti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancerSarita Dubey, Patricia Stephenson, Donna E Levy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307Sarita Dubey, Pasi A Jänne, Lee Krug, et al.
The Journal of Clinical Investigation|May 15, 2026
Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clustersGaelle Haddad, Junyu Guo, Yin Xi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Oncologist|April 12, 2005
Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximabSarita Dubey, Joan H Schiller
Hematology/Oncology Clinics of North America|March 10, 2004
Chemotherapy for advanced non-small cell lung cancerSarita Dubey, Joan H Schiller
The Oncologist|April 5, 2007
Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I diseaseHeather Wakelee, Sarita Dubey, David Gandara
The Lancet. Oncology|May 2, 2006
Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyondSarita Dubey, Jill M Siegfried, Anne M Traynor
Oncology|August 12, 2010
Smoking cessation: an integral part of lung cancer treatmentJanine K Cataldo, Sarita Dubey, Jodi J Prochaska
The Journal of Supportive Oncology|March 31, 2005
Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancerSarita Dubey, Roger L Brown, Sarah L Esmond, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 6, 2006
Phase I study of docetaxel and topotecan in patients with advanced malignanciesSarita Dubey, Paul Hutson, Dona Alberti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancerSarita Dubey, Patricia Stephenson, Donna E Levy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307Sarita Dubey, Pasi A Jänne, Lee Krug, et al.
The Journal of Clinical Investigation|May 15, 2026
Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clustersGaelle Haddad, Junyu Guo, Yin Xi, et al.
Pageof 3